London, 14 May 2024: RX is pleased to announce the appointment of Umang Gupta as the Country General Manager for RX India. Umang, formerly the Marketing Director for Elsevier in India & Southeast Asia, brings extensive experience within the RELX group to his new role, where he will focus on expanding RX's events portfolio in India.
Peter Kumposcht, Managing Director for RX India, commented, "I am thrilled to welcome Umang to our team and am eager to collaborate with him as we further develop our presence in India. His deep understanding of RELX, combined with his knowledge of our business and ethos, will be invaluable as we aim to build upon the successes of RX in India."
Umang Gupta stated, "I am honoured to be a part of the RX India team and am looking forward to contributing to the next phase of growth for RX in India."
Kumposcht emphasized Umang's pivotal role in enhancing RX's exhibitions and digital capabilities in India. He stated, "Umang's leadership will drive our efforts to create smarter events, fostering our communities, enhancing customer businesses, and expanding our remarkable events portfolio in India."
ENDS
About Umang Gupta:
For more information about Umang Gupta, please visit his LinkedIn profile here.
About RX:
RX is a global leader in events and exhibitions, leveraging industry expertise, data, and technology to foster growth for individuals, communities, and organizations. With a presence in 25 countries across 42 industry sectors, RX hosts approximately 350 events annually. Committed to fostering an inclusive work environment, RX empowers businesses through data-driven insights and digital solutions. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, please visit www.rxglobal.com.
About RELX:
RELX is a global provider of information-based analytics and decision tools for professional and business customers, serving clients in over 180 countries with offices in approximately 40 countries. With over 36,000 employees, RELX PLC, the parent company, is publicly traded on the London, Amsterdam, and New York stock exchanges under the ticker symbols: London: REL; Amsterdam: REN; New York: RELX. For the latest market capitalization information, please visit www.relx.com/investors.
Contact Information:
For further inquiries, please contact:
Sarah Kitley-Spencer
Email: Sarah.Kitley-Spencer@rxglobal.com
Telephone: ++44 (0)7813 777947.